Synthesis of novel C-4'-spiro-oxetano-α-L-ribonucleosides.

[1]  R. Kumar,et al.  Chemo-enzymatic synthesis of 3′-O,4′-C-methylene-linked α-L-arabinonucleosides , 2016 .

[2]  Kayla M Borland,et al.  Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future. , 2016, Current topics in medicinal chemistry.

[3]  Yongseok Choi,et al.  Nucleosides with Modified Sugar Ring: Synthesis and Biological Activities , 2016 .

[4]  R. Schinazi,et al.  Synthesis and Evaluation of 2,6-Modified Purine 2'-C-Methyl Ribonucleosides as Inhibitors of HCV Replication. , 2016, ACS medicinal chemistry letters.

[5]  R. Kumar,et al.  Biocatalytic route to C-3'-azido/-hydroxy-C-4'-spiro-oxetanoribonucleosides. , 2015, Carbohydrate research.

[6]  C. Olsen,et al.  Chemoenzymatic synthesis of C-4'-spiro-oxetanoribonucleosides. , 2014, The Journal of organic chemistry.

[7]  Q. Dang,et al.  Syntheses of 4′-spirocyclic phosphono-nucleosides as potential inhibitors of hepatitis C virus NS5B polymerase , 2014 .

[8]  J. McCarville,et al.  Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase. , 2014, Bioorganic & medicinal chemistry letters.

[9]  C. Espiritu,et al.  Use of 2'-spirocyclic ethers in HCV nucleoside design. , 2014, Journal of medicinal chemistry.

[10]  J. Balzarini,et al.  Stereoselective facile synthesis of 2'-spiro pyrimidine pyranonucleosides via their key intermediate 2'-C-cyano analogues. Evaluation of their bioactivity. , 2014, Carbohydrate research.

[11]  B. Samuelsson,et al.  Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymerase. , 2014, Journal of medicinal chemistry.

[12]  Fabien Zoulim,et al.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases , 2013, Nature Reviews Drug Discovery.

[13]  C. Olsen,et al.  Biocatalytic deacylation studies on tetra-O-acyl-β-D-xylofuranosyl nucleosides: synthesis of xylo-LNA monomers. , 2011, The Journal of organic chemistry.

[14]  A. D. Clark,et al.  Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket. , 2011, Journal of medicinal chemistry.

[15]  J. Fernández-Bolaños,et al.  Spiranic d-gluco-configured N-substituted thiohydantoins as potential enzymatic inhibitors , 2010 .

[16]  B. Samuelsson,et al.  2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase. , 2010, Journal of Medicinal Chemistry.

[17]  Jinchao Zhang,et al.  Stereoselective synthesis and biological activity of novel spiro-oxazinanone-C-glycosides , 2008 .

[18]  M. Drew,et al.  Introduction of vinyl and hydroxymethyl functionalities at C-4 of glucose-derived substrates: synthesis of spirocyclic, bicyclic, and tricyclic nucleosides. , 2008, The Journal of organic chemistry.

[19]  M. Drew,et al.  Synthesis of oxepane ring containing monocyclic, conformationally restricted bicyclic and spirocyclic nucleosides from D-glucose: a cycloaddition approach. , 2007, The Journal of organic chemistry.

[20]  A. Roy,et al.  An easy access to spiroannulated glyco-oxetane, -thietane and -azetane rings: synthesis of spironucleosides , 2006 .

[21]  E. De Clercq,et al.  Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity. , 2005, Journal of medicinal chemistry.

[22]  L. Paquette.  Spirocyclic Restriction of Nucleosides , 2004 .

[23]  E. De Clercq,et al.  Synthesis and Biological Evaluation of Novel 1′‐Branched and Spironucleoside Analogues , 2004, Nucleosides, nucleotides & nucleic acids.

[24]  Mirjana Popsavin,et al.  Synthesis and biological evaluation of some novel 4'-thio-L-ribonucleosides with modified nucleobase moieties. , 2003, Bioorganic & medicinal chemistry letters.

[25]  T. Nyholm,et al.  Nucleosides Nucleotides Nucleic Acids , 2003 .

[26]  H. Choo,et al.  L-nucleosides: antiviral activity and molecular mechanism. , 2002, Current topics in medicinal chemistry.

[27]  C. K. Chu,et al.  Molecular Modeling Approach to Understanding the Mode of Action of l-Nucleosides as Antiviral Agents , 2001, Antimicrobial Agents and Chemotherapy.

[28]  R. Schinazi,et al.  Synthesis of 2',3'-dideoxy-3'-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol. , 2000, Carbohydrate research.

[29]  J. Tronchet,et al.  Highly Stereoselective Synthesis and Biological Properties of Nucleoside Analogues Bearing a Spiro Inserted Oxirane Ring , 2000, Nucleosides, nucleotides & nucleic acids.

[30]  R. J. Anderson,et al.  Adenylosuccinate Synthetase: Site of Action of Hydantocidin, a Microbial Phytotoxin , 1996, Plant physiology.

[31]  C. K. Chu,et al.  Nucleosides and Nucleotides as Antitumor and Antiviral Agents , 1993, Springer US.

[32]  T. Kinoshita,et al.  Hydantocidin: a new compound with herbicidal activity from Streptomyces hygroscopicus. , 1991, The Journal of antibiotics.

[33]  M. Kondo,et al.  Structural elucidation and solution conformation of the novel herbicide hydantocidin , 1991 .